313 related articles for article (PubMed ID: 10395825)
1. Molecular and cellular analysis of Grb2 SH3 domain mutants: interaction with Sos and dynamin.
Vidal M; Goudreau N; Cornille F; Cussac D; Gincel E; Garbay C
J Mol Biol; 1999 Jul; 290(3):717-30. PubMed ID: 10395825
[TBL] [Abstract][Full Text] [Related]
2. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.
Lewitzky M; Kardinal C; Gehring NH; Schmidt EK; Konkol B; Eulitz M; Birchmeier W; Schaeper U; Feller SM
Oncogene; 2001 Mar; 20(9):1052-62. PubMed ID: 11314042
[TBL] [Abstract][Full Text] [Related]
3. Dynamin II associates with Grb2 SH3 domain in Ras transformed NIH3T3 cells.
Yoon SY; Koh WS; Lee MK; Park YM; Han MY
Biochem Biophys Res Commun; 1997 May; 234(3):539-43. PubMed ID: 9175747
[TBL] [Abstract][Full Text] [Related]
4. Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2.
Xu XX; Yi T; Tang B; Lambeth JD
Oncogene; 1998 Mar; 16(12):1561-9. PubMed ID: 9569023
[TBL] [Abstract][Full Text] [Related]
5. Differential interactions of the growth factor receptor-bound protein 2 N-SH3 domain with son of sevenless and dynamin. Potential role in the Ras-dependent signaling pathway.
Vidal M; Montiel JL; Cussac D; Cornille F; Duchesne M; Parker F; Tocqué B; Roques BP; Garbay C
J Biol Chem; 1998 Feb; 273(9):5343-8. PubMed ID: 9478994
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of the Grb2 N-terminal SH3 domain complexed with a ten-residue peptide derived from SOS: direct refinement against NOEs, J-couplings and 1H and 13C chemical shifts.
Wittekind M; Mapelli C; Lee V; Goldfarb V; Friedrichs MS; Meyers CA; Mueller L
J Mol Biol; 1997 Apr; 267(4):933-52. PubMed ID: 9135122
[TBL] [Abstract][Full Text] [Related]
8. The crystal structure of the N-terminal SH3 domain of Grb2.
Guruprasad L; Dhanaraj V; Timm D; Blundell TL; Gout I; Waterfield MD
J Mol Biol; 1995 May; 248(4):856-66. PubMed ID: 7752246
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of Grb2-Sos1 interaction: the N-terminal SH3 domain of Grb2 mediates affinity.
Sastry L; Lin W; Wong WT; Di Fiore PP; Scoppa CA; King CR
Oncogene; 1995 Sep; 11(6):1107-12. PubMed ID: 7566970
[TBL] [Abstract][Full Text] [Related]
10. Sam68 associates with the SH3 domains of Grb2 recruiting GAP to the Grb2-SOS complex in insulin receptor signaling.
Najib S; Sánchez-Margalet V
J Cell Biochem; 2002; 86(1):99-106. PubMed ID: 12112020
[TBL] [Abstract][Full Text] [Related]
11. The GTPase dynamin binds to and is activated by a subset of SH3 domains.
Gout I; Dhand R; Hiles ID; Fry MJ; Panayotou G; Das P; Truong O; Totty NF; Hsuan J; Booker GW
Cell; 1993 Oct; 75(1):25-36. PubMed ID: 8402898
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of Grb2 reveals extensive flexibility necessary for target recognition.
Yuzawa S; Yokochi M; Hatanaka H; Ogura K; Kataoka M; Miura K; Mandiyan V; Schlessinger J; Inagaki F
J Mol Biol; 2001 Feb; 306(3):527-37. PubMed ID: 11178911
[TBL] [Abstract][Full Text] [Related]
13. Tight association of GRB2 with receptor protein-tyrosine phosphatase alpha is mediated by the SH2 and C-terminal SH3 domains.
den Hertog J; Hunter T
EMBO J; 1996 Jun; 15(12):3016-27. PubMed ID: 8670803
[TBL] [Abstract][Full Text] [Related]
14. High affinity Grb2-SH3 domain ligand incorporating Cbeta-substituted prolines in a Sos-derived decapeptide.
Jacquot Y; Broutin I; Miclet E; Nicaise M; Lequin O; Goasdoué N; Joss C; Karoyan P; Desmadril M; Ducruix A; Lavielle S
Bioorg Med Chem; 2007 Feb; 15(3):1439-47. PubMed ID: 17113302
[TBL] [Abstract][Full Text] [Related]
15. NMR structure of the N-terminal SH3 domain of GRB2 and its complex with a proline-rich peptide from Sos.
Goudreau N; Cornille F; Duchesne M; Parker F; Tocqué B; Garbay C; Roques BP
Nat Struct Biol; 1994 Dec; 1(12):898-907. PubMed ID: 7773779
[TBL] [Abstract][Full Text] [Related]
16. Design of peptoid analogue dimers and measure of their affinity for Grb2 SH3 domains.
Vidal M; Liu WQ; Lenoir C; Salzmann J; Gresh N; Garbay C
Biochemistry; 2004 Jun; 43(23):7336-44. PubMed ID: 15182177
[TBL] [Abstract][Full Text] [Related]
17. Expression and purification of dynamin II domains and initial studies on structure and function.
Dong J; Misselwitz R; Welfle H; Westermann P
Protein Expr Purif; 2000 Nov; 20(2):314-23. PubMed ID: 11049755
[TBL] [Abstract][Full Text] [Related]
18. Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions.
Simon JA; Schreiber SL
Chem Biol; 1995 Jan; 2(1):53-60. PubMed ID: 9383403
[TBL] [Abstract][Full Text] [Related]
19. The proline-rich region of Vav binds to Grb2 and Grb3-3.
Ramos-Morales F; Romero F; Schweighoffer F; Bismuth G; Camonis J; Tortolero M; Fischer S
Oncogene; 1995 Oct; 11(8):1665-9. PubMed ID: 7478592
[TBL] [Abstract][Full Text] [Related]
20. Competitive binding assay of src homology domain 3 interactions between 5-lipoxygenase and growth factor receptor binding protein 2.
VanderNoot VA; Fitzpatrick FA
Anal Biochem; 1995 Sep; 230(1):108-14. PubMed ID: 8585605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
